Latest Triple test Stories
A new DNA-based prenatal blood test that can strikingly reduce the number of risky diagnostic procedures needed to identify a pregnancy with Down syndrome is ready to be introduced into clinical practice.
In 1980 in the United States, approximately 4.5% of all pregnant women were of advanced maternal age.
A test that uses the latest DNA technology to analyze genetic components in a pregnant woman's blood could predict Down's syndrome in unborn babies, according to new research.
Research published on Tuesday states that DNA in a pregnant woman's blood can reliably show whether her fetus has Down's syndrome, which can reduce the need for invasive testing procedures like amniocentesis.
Lenetix Announces Successful Study of Improved Non-invasive Test Procedure MINEOLA, N.Y., Jan. 28 /PRNewswire/ -- Lenetix, Inc.
A new national screening strategy in Denmark has halved the number of infants born with Down's syndrome and increased the number of infants diagnosed before birth by 30%, according to a study published on bmj.com today.
By Andrew Pollack For three decades, scientists have been trying to develop a noninvasive prenatal test for Down syndrome that would replace amniocentesis, which can cause miscarriages.
By Kate Foster EVERY pregnant woman in Scotland is to be offered an early and highly accurate test to see if their baby has Down's Syndrome.